Showing 12,181 - 12,200 results of 18,566 for search 'significantly ((((we decrease) OR (((a decrease) OR (mean decrease))))) OR (linear decrease))', query time: 0.53s Refine Results
  1. 12181

    Image 1_Expansion of CD57+ CD8 T cells in common variable immunodeficiency with hepatopathy and CMV infection.pdf by Patrick Bez (13168041)

    Published 2025
    “…</p>Results<p>The expansion of CD57<sup>+</sup> CD8 T cells was part of the previously described immune alteration, including altered CD4/CD8 ratio and a decrease in naïve CD4 T cells. The loss of significant association with increasing age might corroborate the suggestion of premature immunosenescence in CVID. …”
  2. 12182

    Table 1_Expansion of CD57+ CD8 T cells in common variable immunodeficiency with hepatopathy and CMV infection.pdf by Patrick Bez (13168041)

    Published 2025
    “…</p>Results<p>The expansion of CD57<sup>+</sup> CD8 T cells was part of the previously described immune alteration, including altered CD4/CD8 ratio and a decrease in naïve CD4 T cells. The loss of significant association with increasing age might corroborate the suggestion of premature immunosenescence in CVID. …”
  3. 12183

    Image_1_Dietary soy protein reverses obesity-induced liver steatosis and alters fecal microbial composition independent of isoflavone level.JPEG by Reza Hakkak (11086)

    Published 2024
    “…Introduction<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major public health concern that is exacerbated by the obesity pandemic. …”
  4. 12184

    Table_1_Dietary soy protein reverses obesity-induced liver steatosis and alters fecal microbial composition independent of isoflavone level.DOCX by Reza Hakkak (11086)

    Published 2024
    “…Introduction<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major public health concern that is exacerbated by the obesity pandemic. …”
  5. 12185

    Image 5_Unexpected estradiol decline during ovarian stimulation monitoring affects cumulative live birth.png by Haixiao Chen (12565087)

    Published 2025
    “…In both unmatched and matched cohorts, the CLBRs were significantly decreased (unmatched cohort: 66.3% versus 55%, P<0.001, adjusted OR 0.83, 95% CI: 0.76,0.91; matched cohort: 59% versus 55%, P = 0.003, adjusted OR 0.84, 95%CI: 0.75,0.94). …”
  6. 12186

    Image 9_Unexpected estradiol decline during ovarian stimulation monitoring affects cumulative live birth.tiff by Haixiao Chen (12565087)

    Published 2025
    “…In both unmatched and matched cohorts, the CLBRs were significantly decreased (unmatched cohort: 66.3% versus 55%, P<0.001, adjusted OR 0.83, 95% CI: 0.76,0.91; matched cohort: 59% versus 55%, P = 0.003, adjusted OR 0.84, 95%CI: 0.75,0.94). …”
  7. 12187

    Image 1_Unexpected estradiol decline during ovarian stimulation monitoring affects cumulative live birth.jpeg by Haixiao Chen (12565087)

    Published 2025
    “…In both unmatched and matched cohorts, the CLBRs were significantly decreased (unmatched cohort: 66.3% versus 55%, P<0.001, adjusted OR 0.83, 95% CI: 0.76,0.91; matched cohort: 59% versus 55%, P = 0.003, adjusted OR 0.84, 95%CI: 0.75,0.94). …”
  8. 12188

    Image 2_Unexpected estradiol decline during ovarian stimulation monitoring affects cumulative live birth.tiff by Haixiao Chen (12565087)

    Published 2025
    “…In both unmatched and matched cohorts, the CLBRs were significantly decreased (unmatched cohort: 66.3% versus 55%, P<0.001, adjusted OR 0.83, 95% CI: 0.76,0.91; matched cohort: 59% versus 55%, P = 0.003, adjusted OR 0.84, 95%CI: 0.75,0.94). …”
  9. 12189

    Image 8_Unexpected estradiol decline during ovarian stimulation monitoring affects cumulative live birth.tiff by Haixiao Chen (12565087)

    Published 2025
    “…In both unmatched and matched cohorts, the CLBRs were significantly decreased (unmatched cohort: 66.3% versus 55%, P<0.001, adjusted OR 0.83, 95% CI: 0.76,0.91; matched cohort: 59% versus 55%, P = 0.003, adjusted OR 0.84, 95%CI: 0.75,0.94). …”
  10. 12190

    Image 7_Unexpected estradiol decline during ovarian stimulation monitoring affects cumulative live birth.tiff by Haixiao Chen (12565087)

    Published 2025
    “…In both unmatched and matched cohorts, the CLBRs were significantly decreased (unmatched cohort: 66.3% versus 55%, P<0.001, adjusted OR 0.83, 95% CI: 0.76,0.91; matched cohort: 59% versus 55%, P = 0.003, adjusted OR 0.84, 95%CI: 0.75,0.94). …”
  11. 12191

    Image 10_Unexpected estradiol decline during ovarian stimulation monitoring affects cumulative live birth.tiff by Haixiao Chen (12565087)

    Published 2025
    “…In both unmatched and matched cohorts, the CLBRs were significantly decreased (unmatched cohort: 66.3% versus 55%, P<0.001, adjusted OR 0.83, 95% CI: 0.76,0.91; matched cohort: 59% versus 55%, P = 0.003, adjusted OR 0.84, 95%CI: 0.75,0.94). …”
  12. 12192

    Image 4_Unexpected estradiol decline during ovarian stimulation monitoring affects cumulative live birth.tiff by Haixiao Chen (12565087)

    Published 2025
    “…In both unmatched and matched cohorts, the CLBRs were significantly decreased (unmatched cohort: 66.3% versus 55%, P<0.001, adjusted OR 0.83, 95% CI: 0.76,0.91; matched cohort: 59% versus 55%, P = 0.003, adjusted OR 0.84, 95%CI: 0.75,0.94). …”
  13. 12193

    Image 6_Unexpected estradiol decline during ovarian stimulation monitoring affects cumulative live birth.tiff by Haixiao Chen (12565087)

    Published 2025
    “…In both unmatched and matched cohorts, the CLBRs were significantly decreased (unmatched cohort: 66.3% versus 55%, P<0.001, adjusted OR 0.83, 95% CI: 0.76,0.91; matched cohort: 59% versus 55%, P = 0.003, adjusted OR 0.84, 95%CI: 0.75,0.94). …”
  14. 12194

    Image 3_Unexpected estradiol decline during ovarian stimulation monitoring affects cumulative live birth.tiff by Haixiao Chen (12565087)

    Published 2025
    “…In both unmatched and matched cohorts, the CLBRs were significantly decreased (unmatched cohort: 66.3% versus 55%, P<0.001, adjusted OR 0.83, 95% CI: 0.76,0.91; matched cohort: 59% versus 55%, P = 0.003, adjusted OR 0.84, 95%CI: 0.75,0.94). …”
  15. 12195

    Data Sheet 1_Enhancing AAV-microdystrophin gene therapy after repeat dosing by blocking phagocytosis.docx by Rita Spathis (187690)

    Published 2025
    “…</p>Results<p>Viral load was significantly increased by 77-fold in white blood cells after two rAAV9-microdystrophin doses compared to mice receiving a single dose. …”
  16. 12196

    Exploring <i>in vitro</i> anticancer potential of <i>Ferula gummosa</i> gum on PC-3 cells: insights from cellular and molecular studies by Negar Abdollahzadeh (20507068)

    Published 2025
    “…In a previous study, we discovered that treating PC-3 cells with <i>Ferula gummosa</i> gum leads to significant cytotoxicity and induces apoptosis. …”
  17. 12197

    Data Sheet 1_Mechanical property changes of glial LC and RGC axons in response to high intraocular pressure.docx by Bochao Ma (14572143)

    Published 2025
    “…Similarly, the Young's modulus of RGC axons decreased by 45.6%, 70.9%, and 75.9% over the same time points. …”
  18. 12198

    Data Sheet 1_The walking surface influences vertical ground reaction force and centre of pressure data obtained with pressure-sensing insoles.pdf by Elke Warmerdam (13895493)

    Published 2024
    “…When analysing gait data measured via insoles during daily living, we recommend to correct for the surface type to decrease variability.…”
  19. 12199

    Table1_Investigation of the effects of Periplaneta americana (L.) extract on ischemic stroke based on combined multi-omics of gut microbiota.XLSX by Xin Yang (104842)

    Published 2024
    “…Improving survival rates and promoting recovery in patients with IS pose significant challenges, however, recent research has identified the gut–brain axis as a therapeutic target. …”
  20. 12200

    DataSheet2_Investigation of the effects of Periplaneta americana (L.) extract on ischemic stroke based on combined multi-omics of gut microbiota.zip by Xin Yang (104842)

    Published 2024
    “…Improving survival rates and promoting recovery in patients with IS pose significant challenges, however, recent research has identified the gut–brain axis as a therapeutic target. …”